Volume 98, Issue 2
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645



Chagas disease has the highest prevalence of any parasitic disease in the Americas, affecting 6–7 million people. Conventional diagnosis requires a well-equipped laboratory with experienced personnel. The development of new diagnostic tools that are easy to use and adapted to the reality of affected populations and health systems is still a significant challenge. The main objective of this study was to measure infection status using saliva samples of infected subjects. Blood and saliva samples from 20 -seropositive individuals and 10 controls were tested for infection using two different commercial serological tests. We have shown that detection of infection is possible using saliva samples, supporting the potential use of saliva to diagnose Chagas disease in humans. This method could provide a simple, low-cost but effective tool for the diagnosis of infection. Its noninvasive nature makes it particularly well suited for endemic areas.


Article metrics loading...

The graphs shown below represent data from March 2017
Loading full text...

Full text loading...



  1. WHO, 2015. Chagas disease (American trypanosomiasis). Available at: http://www.who.int/mediacentre/factsheets/fs340/en/.
  2. Bern C, Kjos S, Yabsley MJ, Montgomery SP, , 2011. Trypanosoma cruzi and Chagas disease in the United States. Clin Microbiol Rev 24: 655681. [Google Scholar]
  3. Gascon J, Bern C, Pinazo MJ, , 2010. Chagas disease in Spain, the United States and other non-endemic countries. Acta Trop 115: 2227. [Google Scholar]
  4. Cohen JE, Gurtler RE, , 2001. Modeling household transmission of American trypanosomiasis. Science 293: 694698. [Google Scholar]
  5. Young C, Losikoff P, Chawla A, Glasser L, Forman E, , 2007. Transfusion-acquired Trypanosoma cruzi infection. Transfusion 47: 540544. [Google Scholar]
  6. Gurtler RE, Segura EL, Cohen JE, , 2003. Congenital transmission of Trypanosoma cruzi infection in Argentina. Emerg Infect Dis 9: 2932. [Google Scholar]
  7. Dias JP, 2008. Acute Chagas disease outbreak associated with oral transmission. Rev Soc Bras Med Trop 41: 296300. [Google Scholar]
  8. Jackson Y, Alirol E, Getaz L, Wolff H, Combescure C, Chappuis F, , 2010. Tolerance and safety of nifurtimox in patients with chronic chagas disease. Clin Infect Dis 51: 6975. [Google Scholar]
  9. Pinazo MJ, Guerrero L, Posada E, Rodríguez E, Soy D, Gascon J, , 2012. Benznidazole-related adverse drug reactions and their relationship to serum drug concentrations in patients with chronic chagas disease. Antimicrob Agents Chemother 57: 390395. [Google Scholar]
  10. Viotti R, Vigliano C, Lococo B, Alvarez MG, Petti M, Bertocchi G, Armenti A, , 2009. Side effects of benznidazole as treatment in chronic Chagas disease: fears and realities. Expert Rev Anti Infect Ther 7: 157163. [Google Scholar]
  11. Urbina JA, , 2009. Specific chemotherapy of Chagas disease: relevance, current limitations and new approaches. Acta Trop 115: 5568. [Google Scholar]
  12. Sguassero Y, Cuesta CB, Roberts KN, Hicks E, Comandé D, Ciapponi A, Sosa-Estani S, , 2015. Course of chronic Trypanosoma cruzi infection after treatment based on parasitological and serological tests: a systematic review of follow-up studies. PLoS One 10: e0139363. [Google Scholar]
  13. Tarleton RL, Reithinger R, Urbina JA, Kitron U, Gürtler RE, , 2007. The challenges of Chagas disease—grim outlook or glimmer of hope? PLoS Med 4: e332. [Google Scholar]
  14. Pfaffe T, Cooper-White J, Beyerlein P, Kostner K, Punyadeera C, , 2011. Diagnostic potential of saliva: current state and future applications. Clin Chem 57: 675687. [Google Scholar]
  15. Kaufman E, Lamste I, , 2002. The diagnostic applications of saliva. Crit Rev Oral Biol Med 13: 197212. [Google Scholar]
  16. Pinho RT, Pedrosa RC, Costa-Martins P, Castello-Branco LRR, , 1999. Saliva ELISA: a method for the diagnosis of chronic Chagas disease in endemic areas. Acta Trop 72: 3138. [Google Scholar]
  17. Fabbro DL, Streiger ML, Arias ED, Bizai ML, del Barco M, Amicone NA, , 2007. Trypanocide treatment among adults with chronic Chagas disease living in Santa Fe city (Argentina), over a mean follow-up of 21 years: parasitological, serological and clinical evolution. Rev Soc Bras Med Trop 40: 110. [Google Scholar]

Data & Media loading...

  • Received : 22 Feb 2017
  • Accepted : 22 Oct 2017
  • Published online : 08 Jan 2018

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error